Clinical Trial Update: Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis [Phase 2]

View source ↗

Summary

Phase 2 trial update for dupilumab in severe eosinophilic chronic rhinosinusitis without nasal polyps. The study is currently active but not recruiting at the U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Eosinophilic Without Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of South Florida | Conditions: Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis | Phase 2 | Status: ACTIVE_NOT_RECRUITING